Cargando…
Early coagulation tests predict risk stratification and prognosis of COVID-19
The ongoing outbreak of Coronavirus Disease 2019 (COVID-19) is hitting the world hard, but the relationship between coagulation disorders and COVID-19 is still not clear. This study aimed to explore whether early coagulation tests can predict risk stratification and prognosis. PubMed, Web of Science...
Autores principales: | Luo, Lili, Xu, Min, Du, Mengyi, Kou, Haiming, Liao, Danying, Cheng, Zhipeng, Mei, Heng, Hu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485702/ https://www.ncbi.nlm.nih.gov/pubmed/32860672 http://dx.doi.org/10.18632/aging.103581 |
Ejemplares similares
-
Plasma proteomic and metabolomic signatures of B‐ALL patients during CAR‐T cell therapy
por: Wu, Jianghua, et al.
Publicado: (2023) -
Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma
por: Du, Mengyi, et al.
Publicado: (2022) -
Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation
por: Wang, Manzhi, et al.
Publicado: (2015) -
Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
por: Luo, Wenjing, et al.
Publicado: (2022) -
Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)